GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blueberries Medical Corp (STU:1OA) » Definitions » Enterprise Value

Blueberries Medical (STU:1OA) Enterprise Value : €2.40 Mil (As of May. 03, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Blueberries Medical Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Blueberries Medical's Enterprise Value is €2.40 Mil. Blueberries Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.78 Mil. Therefore, Blueberries Medical's EV-to-EBIT ratio for today is -3.08.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Blueberries Medical's Enterprise Value is €2.40 Mil. Blueberries Medical's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.70 Mil. Therefore, Blueberries Medical's EV-to-EBITDA ratio for today is -3.42.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Blueberries Medical's Enterprise Value is €2.40 Mil. Blueberries Medical's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €0.18 Mil. Therefore, Blueberries Medical's EV-to-Revenue ratio for today is 13.34.

EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Blueberries Medical's Enterprise Value is €2.40 Mil. Blueberries Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.53 Mil. Therefore, Blueberries Medical's EV-to-FCF ratio for today is -4.56.


Blueberries Medical Enterprise Value Historical Data

The historical data trend for Blueberries Medical's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blueberries Medical Enterprise Value Chart

Blueberries Medical Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.41 7.67 6.62 2.46 2.24

Blueberries Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.10 2.24 3.57 1.70 3.03

Competitive Comparison of Blueberries Medical's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blueberries Medical's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Blueberries Medical's Enterprise Value falls into.


;
;

Blueberries Medical Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Blueberries Medical's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Blueberries Medical's Enterprise Value for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blueberries Medical  (STU:1OA) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Blueberries Medical's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2.401/-0.779
=-3.08

Blueberries Medical's current Enterprise Value is €2.40 Mil.
Blueberries Medical's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.78 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Blueberries Medical's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=2.401/-0.702
=-3.42

Blueberries Medical's current Enterprise Value is €2.40 Mil.
Blueberries Medical's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.70 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Blueberries Medical's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2.401/0.18
=13.34

Blueberries Medical's current Enterprise Value is €2.40 Mil.
Blueberries Medical's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.18 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Blueberries Medical's EV-to-FCF for today is:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2.401/-0.526
=-4.56

Blueberries Medical's current Enterprise Value is €2.40 Mil.
Blueberries Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blueberries Medical Enterprise Value Related Terms

Thank you for viewing the detailed overview of Blueberries Medical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Blueberries Medical Business Description

Traded in Other Exchanges
Address
8500 West Georgia Street, Suite 2200, Vancouve, BC, CAN, V6C 3E8
Blueberries Medical Corp is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.

Blueberries Medical Headlines

No Headlines